Cherry angioma (syn. angioma, Campbell de Morgan spots)

LAST UPDATED: Jun 05, 2026

Patient Information Leaflet
Link: Angioma

https://www.pcds.org.uk/patient-info-leaflets/angioma

Introduction

An angioma is a benign acquired vascular proliferation of the skin. The term cherry angioma is often used to describe angiomas with a cherry-like (or blackberry-like) appearance. The term Campbell de Morgan spots is sometimes used if there are numerous small angiomas.

This chapter is set out as follows:


History

  • Usually asymptomatic
  • Surface bleeding, or a bled into the surrounding skin, can occur if traumatised (including at sites of friction)
  • Lesion can thrombose, suddenly turning black 

Clinical findings

Clinical features

  • One to many - numbers increase with age
  • Any body surface; most commonly the trunk
  • Soft papules and nodules; partially compressible
  • Colour - often red-purple, occasionally blue-purple. Black if thrombosed
  • The surrounding skin usually normal unless the angioma has bled into the skin
  • If scale present most likely an angiokeratoma (refer to related chapter)

Dermoscopic features (hover over the underlined words for explanation of terminology) 

  • Multiple lacunae
  • Most lacunae are well-demarcated and separated by white fibrous stroma (some lesions can be a little hazy with more white fibrous stroma - refer to dermoscopic images 11-13)
  • In most angiomas, individual vessels are not seen. Occasionally a few small vessels may be seen at the periphery
  • The presence of any other colour (eg brown) and/or blood vessels running through the lesion are red flags with melanoma being a differential. Click here for an overview of dermoscopic vessel patterns in skin lesions

Clinical Images

Please refer to notes on image rights at bottom of the page with regards to individual image ownership.


Management

  • Treatment is not normally required
  • Lesions that catch / bleed can be removed by curettage and sent for histology

Disclaimer - the author PCDS cannot accept responsibility for any misleading or incorrect statements, and the management of individual patients remains the direct responsibility of the individual doctor. We do however hope that visitors to this site can contact us regarding comments that are considered misleading or incorrect so that we can continue to improve the site.

Image Rights - The PCDS would like to thank Dermatoweb, DermQuest (Galderma), and others who have contributed images. All named individuals and organisations maintain copyright for the relevant images.

Quick Links

The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes

Almirall
Galderma
Glenmark
Johnson & Johnson
La Roche-Posay
LEO Pharma
Pierre Fabre
Schuco